Stock 002907 CHONGQING PHARSCIN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Chongqing Pharscin Pharmaceutical Co., Ltd.

Equities

002907

CNE100003308

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-16 pm EDT 		5-day change 1st Jan Change
12.99 CNY +6.13% Intraday chart for Chongqing Pharscin Pharmaceutical Co., Ltd. -6.41% -15.92%
Apr. 03 Pharscin Pharma Gets License to Produce Olmesartan Medoxomil Amlodipine Tablets MT
Jan. 24 Pharscin Pharmaceutical Amends Colon Cleanser Drug's Validity Period MT

Business Summary

Chongqing Pharscin Pharmaceutical Co Ltd is a China-based company principally engaged in the research, development, production and sale of Chinese patent drugs and chemical drugs. The Company operates three segments: Pharmaceutical Industry segment, Commercial Circulation segment and Retail segment. The Company's products are categorized into the pharmaceuticals of digestive system, nervous system, otorhinolaryngology, cardiovascular and cerebrovascular systems and immune systems. The Company’s products include Weidimei (aluminum carbonate tablets), Ganju Bingmei Tablets, Bawei Qilong Particles, Liuwei Anshen Capsules, Sodium Ferulate for Injection, Omeprazole Sodium for Injection and Gabexate Mesilate for Injection. The Company mainly distributes its products in domestic market.

Number of employees: 1,416

Sales per Business

CNY in Million2022Weight2023Weight Delta
Ear, Nose and Throat Medication
29.9 %
257 32.7 % 207 29.9 % -19.54%
Digestive System Medication
23.2 %
197 25.1 % 160 23.2 % -18.76%
Psychiatric and Nervous System Medication
19.0 %
122 15.6 % 132 19.0 % +7.75%
Pharmaceutical
16.5 %
113 14.3 % 114 16.5 % +1.10%
Medication in Other Fields
7.4 %
60 7.6 % 51 7.4 % -14.58%
Hormones and Drugs Regulating Endocrine Functions
2.1 %
24 3.1 % 15 2.1 % -39.20%
Other Business
1.5 %
10 1.3 % 11 1.5 % +2.23%
Pharmaceutical Retail
0.4 %
2 0.3 % 3 0.4 % +36.13%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
785 100.0 % 692 100.0 % -11.93%

Managers

Managers TitleAgeSince
Xiao Ying Liu CEO
 Chief Executive Officer 61 15-08-18
Kai Yu Xu CHM
 Chairman 58 00-09-30
Xiao Yan Peng DFI
 Director of Finance/CFO 50 02-02-28
Ling Zhang BRD
 Director/Board Member 36 14-05-31
Xue Dan You BRD
 Director/Board Member 36 14-06-30
Ying Wang BRD
 Director/Board Member 62 15-08-18

Members of the board

Members of the board TitleAgeSince
Jia Ming Li BRD
 Director/Board Member 58 22-05-17
Shou Ying Du BRD
 Director/Board Member 64 20-04-30
Hong Tao You CHM
 Chairman 61 15-08-18
Xiao Ying Liu CEO
 Chief Executive Officer 61 15-08-18
Ying Wang BRD
 Director/Board Member 62 15-08-18
Yan Liang BRD
 Director/Board Member 55 16-04-24
Xue Dan You BRD
 Director/Board Member 36 14-06-30
Kai Yu Xu CHM
 Chairman 58 00-09-30
Zhi Chun Deng BRD
 Director/Board Member 60 12-11-30
Ling Zhang BRD
 Director/Board Member 36 14-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 417,596,314 76,562,235 ( 18.33 %) 0 18.33 %

Shareholders

NameEquities%Valuation
Yi Zhu You
65.85 %
188,100,000 65.85 % 365 M ¥
Hong Tao You
4.795 %
13,697,000 4.795 % 27 M ¥
Xiao Ying Liu
3.141 %
8,973,670 3.141 % 17 M ¥
Ying Wang
2.416 %
6,900,000 2.416 % 13 M ¥
Zhong You Wang
0.7596 %
2,169,900 0.7596 % 4 M ¥
Man Hong Lai
0.2044 %
583,909 0.2044 % 1 M ¥
Zhi Ming Zhu
0.1419 %
405,200 0.1419 % 786 019 ¥
Yu Jie Li
0.1243 %
355,114 0.1243 % 688 861 ¥
Wei Xu
0.1143 %
326,600 0.1143 % 633 548 ¥
Lin Wang Wang
0.1136 %
324,600 0.1136 % 629 669 ¥
NameEquities%Valuation
Hong Tao You
50.87 %
58,725,000 50.87 % 114 M ¥
Ying Wang
25.73 %
29,700,000 25.73 % 58 M ¥
Xiao Ying Liu
23.32 %
26,921,009 23.32 % 52 M ¥
Xiao Yan Peng
0.0152 %
17,500 0.0152 % 33 947 ¥
CPIC Fund Management Co. Ltd.
0.001281 %
1,479 0.001281 % 2 869 ¥

Company contact information

Chongqing Pharscin Pharmaceutical Co., Ltd.

89 Middle Section of Huangshan Yubei District

401120, Chongqing

+86 23 6762 2999

http://www.pharscin.com
address Chongqing Pharscin Pharmaceutical Co., Ltd.(002907)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sector Generic Pharmaceuticals

1st Jan change Capi.
CHONGQING PHARSCIN PHARMACEUTICAL CO., LTD. Stock Chongqing Pharscin Pharmaceutical Co., Ltd.
-15.92% 749M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.40% 44.1B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+17.11% 21.97B
CIPLA LIMITED Stock Cipla Limited
+8.10% 13.27B
SANDOZ GROUP AG Stock Sandoz Group AG
+7.13% 13.22B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+35.95% 11.36B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.53% 7.07B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+10.09% 5.23B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002907 Stock
  4. Company Chongqing Pharscin Pharmaceutical Co., Ltd.